Lifespan based pharmacokinetic-pharmacodynamic model of tumor growth inhibition by anticancer therapeutics.
Accurate prediction of tumor growth is critical in modeling the effects of anti-tumor agents. Popular models of tumor growth inhibition (TGI) generally offer empirical description of tumor growth. We propose a lifespan-based tumor growth inhibition (LS TGI) model that describes tumor growth in a xen...
Main Authors: | Gary Mo, Frank Gibbons, Patricia Schroeder, Wojciech Krzyzanski |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4204849?pdf=render |
Similar Items
-
Pharmacokinetics and Pharmacodynamics Models of Tumor Growth and Anticancer Effects in Discrete Time
by: Atıcı Ferhan M., et al.
Published: (2020-10-01) -
Pharmacokinetics and pharmacodynamics of therapeutic antibodies in tumors and tumor-draining lymph nodes
by: Eric Salgado, et al.
Published: (2021-04-01) -
Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice
by: Javier Reig-López, et al.
Published: (2020-10-01) -
Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole
by: Dave, Nimita D.
Published: (2013) -
Pharmacokinetic and pharmacodynamic
by: 蔡東湖
Published: (1995)